MiddleBrook Aims To Address $600 Million Strep Market With Moxatag
This article was originally published in The Pink Sheet Daily
Company plans to launch the first once-daily amoxicillin formulation for patients over 12 in the fall.
You may also be interested in...
Firm plans to resubmit application with additional information in March.
Firm may need to manufacture commercial-sized quantities of antibiotic in order for FDA to accept the submission.
Court rules that Advancis name infringes on Sanofi-Aventis' trademark and orders the two firms to submit a proposed order by Oct. 23.